Blog

Unbind opfOpenEnd w sj evt re opfOpenStart else function be var et chromewebstore item chromeinline extn ef ft ot ge opalpers anch flyout onP appHTML if ildNodes moveChild for . test true l d f try ntentWindow catch main p javascript var void . Overall survival in the TC or IC population was improved with atezolizumab compared docetaxel median months CI vs HR . and our Bing your search engineGet smarter earn rewards faster by adding the New Tab with extension. var Feedback function use strict tAttribute id genId . end new Date Image c Url if var | fairooz kabbinavar md language:en

Length do if ift r art break . We assessed its efficacy and safety versus docetaxel in previously treated patients with nonsmall cell lung did randomised openlabel phase trial OAK academic or community oncology centres countries. Overall survival in the TC or IC population was improved with atezolizumab compared docetaxel median months CI vs HR

The primary efficacy analysis was done in first of enrolled patients. le function SharedLogHelper . In the primary population patients were randomly assigned to receive atezolizumab docetaxel. One death from respiratory tract infection was reported the docetaxel our knowledge OAK is first randomised phase study results of PDL targeted therapy with atezolizumab treatment resulting clinically relevant improvement overall survival versus previously treated nonsmall cell lung cancer regardless expression histology favourable safety HoffmannLa Roche Ltd Genentech Inc article issueNext articlesCiting Members Group are listed appendix Elsevier . unbind opfOpenEnd w sj evt re opfOpenStart else function be var et chromewebstore item chromeinline extn ef ft ot ge opalpers anch flyout onP appHTML if ildNodes moveChild for . push while t. length f o sb ie return if function a var ge hps sj ce span url default homepage endChild try catch isHomepage http main cook SRCHS PC padding px margin

Var Feedback function use strict tAttribute id genId . P var d appendChild g createElement src k div f iframe document yle. write b place g d ose . Coprimary endpoints were overall survival the intentionto treat ITT and PDL expression population TC or IC tumour cells immune . P a. tps science article pii Atezolizumab is humanised antiprogrammed deathligand PDL monoclonal antibody that inhibits interactions reinvigorating anticancer immunity. for var t in return rt function tualr y if . end new Date Image c Url if var . We enrolled patients who had squamous or nonsquamous nonsmall cell lung cancer were years older measurable disease per Response Evaluation Criteria in Solid Tumors and Eastern Cooperative Oncology Group performance status of